Share URL
Embed chart view
StockViz
Werewolf Therapeutics, Inc.
NasdaqGS:HOWL
Sector
Industries
Location
Market Cap
USD 58.53 M
Share Price
USD 1.28
Avg Daily Volume
409,496
Change (1 day)
3.23%
Change (1 year)
-42.34%
Change (YTD)
-13.51%
Werewolf Therapeutics, Inc. Enterprise Value to EBITDA (EV/EBITDA) on August 21, 2025
Werewolf Therapeutics, Inc. Enterprise Value to EBITDA (EV/EBITDA) is NA on August 21, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Werewolf Therapeutics, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 0.29 on August 21, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Werewolf Therapeutics, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -1.31 on August 21, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Werewolf Therapeutics, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -0.14.
Competitors
Eli Lilly and Company
USD 709.82
LLY
+4.38
0.62%
AbbVie Inc.
USD 209.50
ABBV
+0.35
0.17%
Roche Holding AG
USD 339.30
RO.SW
-2.14
-0.63%
Novartis AG
USD 127.19
NOVN.SW
-0.09
-0.07%
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
+1.42
2.64%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 86.08
MRK
+1.42
1.68%
Thermo Fisher Scientific Inc.
USD 483.76
TMO
-11.05
-2.23%
Amgen Inc.
USD 295.76
AMGN
-0.69
-0.23%
Pfizer Inc.
USD 25.74
PFE
+0.36
1.42%
Gilead Sciences, Inc.
USD 116.14
GILD
-2.59
-2.18%
Sanofi
USD 101.52
SAN.PA
+0.13
0.13%
Vertex Pharmaceuticals Incorporated
USD 397.46
VRTX
+3.10
0.79%
Bristol-Myers Squibb Company
USD 48.43
BMY
+0.17
0.35%
Chugai Pharmaceutical Co., Ltd.
USD 42.04
4519.T
-0.42
-0.99%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Eli Lilly and Company
USD 709.82
LLY
+4.38
0.62%
AbbVie Inc.
USD 209.50
ABBV
+0.35
0.17%
Roche Holding AG
USD 339.30
RO.SW
-2.14
-0.63%
Novartis AG
USD 127.19
NOVN.SW
-0.09
-0.07%
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
+1.42
2.64%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 86.08
MRK
+1.42
1.68%
Thermo Fisher Scientific Inc.
USD 483.76
TMO
-11.05
-2.23%
Amgen Inc.
USD 295.76
AMGN
-0.69
-0.23%
Pfizer Inc.
USD 25.74
PFE
+0.36
1.42%
Gilead Sciences, Inc.
USD 116.14
GILD
-2.59
-2.18%
Sanofi
USD 101.52
SAN.PA
+0.13
0.13%
Vertex Pharmaceuticals Incorporated
USD 397.46
VRTX
+3.10
0.79%
Bristol-Myers Squibb Company
USD 48.43
BMY
+0.17
0.35%
Chugai Pharmaceutical Co., Ltd.
USD 42.04
4519.T
-0.42
-0.99%